"Headquartered in Silicon Valley, CA, HALO Diagnostics leverages cutting-edge artificial intelligence and machine learning, along with the latest in advanced imaging and diagnostic biomarkers to deliver more holistic diagnostic insights and significant improvement in patient experience and outcomes. A foundational element of this combination is the creation of the HALO Diagnostics’ Center of Innovation, formerly known as Desert Medical Imaging, in Indian Wells, CA. The center helps fulfill HALO Diagnostics’ mission of improving human health and well-being via local and easy access to advanced diagnostics and image-guided therapy options."

During the past decade, Desert Medical Imaging conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Desert Medical Imaging" #1 collaborator was "HALO Affiliate Sites" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Desert Medical Imaging" are "Prostate Cancer" (2 trials), "Ankylosing Spondylitis" (1 trials), "Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Central Nervous System Diseases" (1 trials). Many other conditions were trialed in "Desert Medical Imaging" in a lesser frequency.

Most popular intervention types in "Desert Medical Imaging" are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Axumin PET/CT" (1 trials), "Dotarem (gadoterate meglumine)" (1 trials), "MR-guided laser focal therapy" (1 trials), "Magnevist (gadopentetate dimeglumine)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Desert Medical Imaging" are 3 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Desert Medical Imaging". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Desert Medical Imaging, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Desert Medical Imaging, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".